drugset / Trial / NCT06511570
A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
Non-randomizedParallel-groupOpen-labelTreatment
Summary
A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants
Timeline
- Start
- 2024-06-25
- Primary completion
- 2024-09-17
- Completion
- 2024-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sabirnetug | Monoclonal antibody | — | Intravenous |
| Background | rHuPH20 | Protein / enzyme biologic | — | Subcutaneous |